Automatic immunoassay analyzer Evidence RABTA

for clinical diagnosticbiochipbiochip array

The new RABTA (Random Access Biochip Technology Analyser) sets a high standard in laboratory diagnostics by combining advanced biochip technology with outstanding efficiency. Designed for seamless operation, the RABTA platform enables uninterrupted workflows and higher productivity. With rapid random-access capabilities, it delivers precise, reliable results across diverse assays. Featuring five intuitive modules, RABTA simplifies high-throughput analysis, helping clinicians perform complex assays quickly and accurately. Each module is tailored for specific functions, supporting easy integration into diagnostics and advanced research. Its random-access design enables simultaneous processing of multiple samples, making it essential for modern labs. Key Features: High Throughput: Processes up to 60 samples/hour, delivering up to 2,640 test results/hour and 19,580 test results/day. Random Access: Performs multiple tests on various samples simultaneously, removing batch testing constraints. Priority Sampling: Advanced software allows critical samples to be flagged for faster processing and reporting. Rapid Results: First result in just 36 minutes; subsequent results released at one per minute. Intelligent software optimises testing order for efficiency. Zero Carry-Over Risk: Uses single-use tips for aspiration and dispensing, ensuring each result’s integrity. Multiplex Testing: Innovative Biochip Array Technology detects up to 44 targets from a single patient sample, saving time and resources. The RABTA analyser transforms diagnostic workflows, delivering speed, accuracy, and flexibility to meet the evolving demands of modern laboratories.